Exploring the significance of <scp>PAK1</scp> through chromosome conformation signatures in ibrutinib‐resistant chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Exploring the significance of PAK1 through chromosome conformation signatures in ibrutinib‐resistant chronic lymphocytic leukaemia

Published:2022-07-22 Issue:16 Volume:16 Page:2920-2935
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Wu Zijuan¹²³^ORCID,Wang Luqiao¹²³,Fan Lei¹²³^ORCID,Tang Hanning¹²³,Zuo Xiaoling¹²³,Gu Danling¹²³,Lu Xueying¹²³,Li Yue¹²³,Wu Jiazhu¹²³,Qin Shuchao¹²³,Xia Yi¹²³,Zhu Huayuan¹²³,Wang Li¹²³,Xu Wei¹²³,Li Jianyong¹²³⁴,Jin Hui¹²³⁴

Affiliation:

1. Department of Hematology, Pukou CLL Center, Jiangsu Province Hospital The First Affiliated Hospital of Nanjing Medical University China

2. Key Laboratory of Hematology of Nanjing Medical University China

3. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine Nanjing Medical University China

4. National Clinical Research Center for Hematologic Diseases The First Affiliated Hospital of Soochow University Suzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13281

Reference45 articles.

1. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment